Digirad Corporation (DRAD) News
Filter DRAD News Items
DRAD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest DRAD News From Around the Web
Below are the latest news stories about Digirad Corp that investors may wish to consider to help them evaluate DRAD as an investment opportunity.
Digirad To Change Name To Star Equity Holdings; Top Analyst Sees 116% UpsideDigirad Corp. announced on Dec. 28 that it will change its corporate name to Star Equity Holdings effective from Jan. 1. Shares of the diagnostic imaging solutions company gained 2.5% in after-hours trading on Monday. As a result of the name change, Digirad’s (DRAD) common stock will begin trading under the new ticker symbol STRR at the opening on Jan. 4. The company’s series A cumulative perpetual preferred stock will start trading under the new ticker symbol STRRP. Digirad confirmed that the corporate name change would not affect the company’s stockholder rights. Meanwhile, the company’s healthcare division will continue to operate under the brand names Digirad and Digirad Health. |
Digirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.Name Change Effective as of January 1, 2021 No Change to Names of Customer-Facing BusinessesSUWANEE, Ga., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD; DRADP) (the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, announced today that it has changed its corporate name to Star Equity Holdings, Inc. (“Star Equity Holdings”) with an effective date of January 1, 2021 (“Effective Date”). The website for Star Equity Holdings will be www.starequity.com. In connection with the corporate name change, the Company’s Common Stock will begin trading under the new ticker symbol “STRR” and have a CUSIP of 85513Q103, and the Company’s Series A Cumulative Perpetual Preferred Stock will begin tradin... |
Digirad Corporation's (NASDAQ:DRAD) Path To ProfitabilityWith the business potentially at an important milestone, we thought we'd take a closer look at Digirad Corporation's... |
Earnings Scheduled For November 13, 2020 - Stocks News FeedCompanies Reporting Before The Bell • Bio-Path Holdings (NASDAQ:BPTH) is expected to report earnings for its third quarter. • DraftKings (NASDAQ:DKNG) is expected to report quarterly loss at $0.61 per share on revenue of $131.75 million. • Digirad (NASDAQ:DRAD) is estimated to report quarterly earnings at $0.15 per share on revenue of $30.72 million. •… Read More »Earnings Scheduled For November 13, 2020 |
Cisco Systems, DraftKings rise; Digirad fallsStocks that moved heavily or traded substantially Friday: Cisco Systems, DraftKings rise; Digirad falls |
CT Scanners Market 2020: Top Key Players Are Scanco Medical, CT Imaging, PointNix, Neurologica, Hitachi, Digirad, Koning Corporation, Gamma Star, Mediso, SinoVision And GE Healthcare.Industry Overview: Updated research report on CT Scanners Market by ‘Market Growth Insight’ delivers pivotal information on the market including drivers, restraints, challenges, and opportunities. The CT Scanners report is useful to business owners, manufacturers, distributors, suppliers, marketing personnel, strategists, and |
Digirad Corporation to Release Third Quarter 2020 Financial Results on November 13SUWANEE, Ga., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company… |
Digirad News: Why DRAD Stock Is Soaring 28% TodayDigirad (DRAD) news for Wednesday includes the sale of part of its business for $18.75 million pushing DRAD stock higher. |
Digirad Shares Up on Plan to Sell Mobile Medical-Imaging UnitDigirad will sell DMS Health Technologies, a provider of mobile medical-imaging services, for $18.8 million. |
Analyzing Varian Medical Systems (NYSE:VAR) and Digirad (NYSE:DRAD)Varian Medical Systems (NYSE:VAR) and Digirad (NASDAQ:DRAD) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation. Analyst Recommendations This is a summary of current recommendations and price targets for Varian Medical Systems […] |